FDA
approval
· 2018-04-17
FDA Approved: MIGLUSTAT — Original Application (ANI Pharmaceuticals, Inc.)
Summary
The FDA approved ANI Pharmaceuticals' miglustat original-application product (generic miglustat). It is indicated for Niemann-Pick disease type C.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for MIGLUSTAT (MIGLUSTAT)